110,897 Stevanato Group S.p.A. $STVN Shares Sold by Van Berkom & Associates Inc.

Key Points

• Van Berkom & Associates cut its Stevanato Group stake by 3.7%, selling 110,897 shares in the third quarter. It retained 2,858,323 shares, valued at about $60 million.
• Stevanato reported quarterly EPS of €0.16, below analysts’ €0.17 consensus, on revenue of €326.06 million. Analysts’ views were mixed, though MarketBeat’s consensus rating remained “Moderate Buy.”
• Insider Mauro Stocchi sold 13,649 shares at an average €21.50, reducing his direct holdings by 3.3% to 400,000 shares.

Van Berkom & Associates Inc. lowered its stake in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 3.7% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 2,858,323 shares of the company's stock after selling 110,897 shares during the period. Stevanato Group makes up 2.1% of Van Berkom & Associates Inc.'s portfolio, making the stock its 27th largest holding. Van Berkom & Associates Inc. owned 0.94% of Stevanato Group worth $59,968,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Squarepoint Ops LLC boosted its holdings in shares of Stevanato Group by 131.2% during the second quarter. Squarepoint Ops LLC now owns 193,311 shares of the company's stock worth $3,493,000 after acquiring an additional 109,702 shares during the period. Wellington Management Group LLP acquired a new position in shares of Stevanato Group in the second quarter valued at approximately $22,621,000. Fenimore Asset Management Inc acquired a new position in shares of Stevanato Group in the third quarter valued at approximately $12,212,000. Confluence Investment Management LLC bought a new position in shares of Stevanato Group during the second quarter worth approximately $6,062,000. Finally, Royal Bank of Canada increased its stake in shares of Stevanato Group by 15.8% during the first quarter. Royal Bank of Canada now owns 421,696 shares of the company's stock worth $5,798,000 after purchasing an additional 57,536 shares during the period.

Insider Buying and Selling at Stevanato Group

In other news, insider Mauro Stocchi sold 13,649 shares of the company's stock in a transaction on Monday, September 28th. The stock was sold at an average price of €21.50, for a total transaction of €293,453.50. Following the completion of the sale, the insider directly owned 400,000 shares in the company, valued at approximately €8,600,000. This represents a 3.30% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Stevanato Group Stock Performance

Shares of NYSE:STVN opened at €13.68 on Tuesday. The company's 50 day moving average price is €19.65 and its two-hundred day moving average price is €17.98. Stevanato Group S.p.A. has a 12-month low of €12.05 and a 12-month high of €25.45. The firm has a market cap of $4.14 billion, a PE ratio of 23.58, a PEG ratio of 1.15 and a beta of 0.80. The company has a quick ratio of 1.08, a current ratio of 1.73 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVN - Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The company reported €0.16 earnings per share for the quarter, missing analysts' consensus estimates of €0.17 by (€0.01). The business had revenue of €326.06 million during the quarter. Stevanato Group had a net margin of 11.24% and a return on equity of 10.51%. Equities research analysts predict that Stevanato Group S.p.A. will post 0.67 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on STVN. Citigroup dropped their price target on Stevanato Group from $26.00 to $20.00 and set a "buy" rating for the company in a report on Wednesday, November 4th. William Blair lowered Stevanato Group from an "outperform" rating to a "market perform" rating in a report on Wednesday, November 4th. Deutsche Bank Aktiengesellschaft began coverage on Stevanato Group in a research report on Wednesday, October 7th. They set a "hold" rating on the stock. UBS Group dropped their target price on Stevanato Group from $23.00 to $16.00 and set a "neutral" rating for the company in a report on Wednesday, November 4th. Finally, Weiss Ratings raised shares of Stevanato Group from a "hold (c-)" rating to a "hold (c)" rating in a research report on Thursday, August 27th. Two research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy".

Stevanato Group Company Profile

Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector.

The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.

Stevanato Group also designs and manufactures equipment and technologies used to produce, inspect and package pharmaceutical containers and delivery systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.